These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia. Boutlis CS; Weinberg JB; Baker J; Bockarie MJ; Mgone CS; Cheng Q; Anstey NM Infect Immun; 2004 Dec; 72(12):6932-8. PubMed ID: 15557614 [TBL] [Abstract][Full Text] [Related]
4. Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Keller CC; Kremsner PG; Hittner JB; Misukonis MA; Weinberg JB; Perkins DJ Infect Immun; 2004 Aug; 72(8):4868-73. PubMed ID: 15271950 [TBL] [Abstract][Full Text] [Related]
5. Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children. Anstey NM; Weinberg JB; Wang Z; Mwaikambo ED; Duffy PE; Granger DL Am J Trop Med Hyg; 1999 Aug; 61(2):253-8. PubMed ID: 10463676 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Boutlis CS; Gowda DC; Naik RS; Maguire GP; Mgone CS; Bockarie MJ; Lagog M; Ibam E; Lorry K; Anstey NM Infect Immun; 2002 Sep; 70(9):5052-7. PubMed ID: 12183552 [TBL] [Abstract][Full Text] [Related]
7. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515 [TBL] [Abstract][Full Text] [Related]
8. Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity. Han C; Lin Y; Shan G; Zhang Z; Sun X; Wang Z; Wei C; Deng Y; Zhang L; Bu L; Shao D; Wang H Clin Vaccine Immunol; 2010 Oct; 17(10):1524-32. PubMed ID: 20702656 [TBL] [Abstract][Full Text] [Related]
9. Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults. Phawong C; Ouma C; Tangteerawatana P; Thongshoob J; Were T; Mahakunkijcharoen Y; Wattanasirichaigoon D; Perkins DJ; Khusmith S Immunogenetics; 2010 Jun; 62(6):345-56. PubMed ID: 20387064 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-beta) in Plasmodium falciparum malaria. Malaguarnera L; Pignatelli S; Simporè J; Malaguarnera M; Musumeci S Eur Cytokine Netw; 2002; 13(4):425-30. PubMed ID: 12517727 [TBL] [Abstract][Full Text] [Related]
12. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria. Perkins DJ; Kremsner PG; Schmid D; Misukonis MA; Kelly MA; Weinberg JB Infect Immun; 1999 Sep; 67(9):4977-81. PubMed ID: 10456963 [TBL] [Abstract][Full Text] [Related]
13. IL12B polymorphisms are linked but not associated with Plasmodium falciparum parasitemia: a familial study in Burkina Faso. Barbier M; Atkinson A; Fumoux F; Rihet P Genes Immun; 2008 Jul; 9(5):405-11. PubMed ID: 18449199 [TBL] [Abstract][Full Text] [Related]